1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. SEER*Explorer Application [Internet]. [cited 2021 May 22]. Available from: https://seer.cancer.gov/explorer/application.html?site=71&data_type=4&graph_type=5&compareBy=stage&chk_stage_101=101&chk_stage_106=106&series=9&sex=1&race=1&age_range=1&advopt_precision=1&advopt_show_ci=on.
3. Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology;Flaig;J Natl Compr Cancer Netw JNCCN,2020
4. Research C for DE and FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma. FDA [Internet]; 2019 Dec 20 [cited 2021 Nov 14]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-erdafitinib-metastatic-urothelial-carcinoma.
5. Research C for DE and. FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer. FDA [Internet]; 2021 Jul 12 [cited 2021 Nov 14]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-enfortumab-vedotin-ejfv-locally-advanced-or-metastatic-urothelial-cancer.